Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats

Journal of Ethnopharmacology

Volumn 96, Issue 3, 2005, Pages 537-544

  Gong, Li Kun ^a,b   Li, Xiang Hong ^a   Wang, Hui ^a   Zhang, Ling ^c   Chen, Fang Ping ^a,b   Cai, Yan ^a,b   Qi, Xin Ming ^a,b   Liu, Lin Lin ^a,b   Liu, Yong Zhen ^a   Wu, Xiong Fei ^a,b   Huang, Cheng Gang ^a   Ren, Jin ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c SHANGHAI PULMONARY HOSPITAL   (China)

Author keywords

Bleomycin; Collagen; Feitai; Pulmonary fibrosis

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 1; EOSIN; FEITAI; HEMATOXYLIN; HERBACEOUS AGENT; HYDROXYPROLINE; LACTATE DEHYDROGENASE; MALONALDEHYDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL LINE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG FIBROSIS; LUNG LAVAGE; MALE; NONHUMAN; PROTEIN CONTENT; RAT; STAINING; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; LIPID PEROXIDATION; LUNG; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA;

ADMINISTRATION, ORAL; ANIMALS; BLEOMYCIN; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE; CELL LINE; CELL PROLIFERATION; COLLAGEN TYPE I; DRUGS, CHINESE HERBAL; HUMANS; HYDROXYPROLINE; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; LUNG; MALE; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 21644448511     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2004.09.046     Document Type: Article

References (35)

1. Adler, S., Shimaoka, K., Tsukada, Y., 1976. Letter: Bleomycin toxicity. Journal of the American Medical Association 235, 2814.
2. Arai, T., Abe, K., Matsuoka, H., Yoshida, M., Mori, M., Goya, S., Kida, H., Nishino, K., Osaki, T., Tachibana, I., Kaneda, Y., Hayashi, S., 2000. Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. American Journal of Physiology, Lung Cellular and Molecular Physiology 278, 914-922.
3. Aso, Y., Toneda, K., Kikkawa, Y., 1976. Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Laboratory Investigation 35, 558-568.
4. Cortijo, J., Cerda-Nicolas, M., Serrano, A., Bioque, G., Estrela, J.M., Santangelo, F., Esteras, A., Llombart-Bosch, A., Morcillo, E.J., 2001. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. The European Respiratory Journal 17, 1228-1235.
5. Crouch, E., 1990. Pathology of pulmonary fibrosis. The American Journal of Physiology 259, 159-184.
6. Daba, M.H., Abdel-Aziz, A.A., Moustafa, A.M., Al-Majed, A.A., Al-Shabanah, O.A., El-Kashef, H.A., 2002. Effects of L-carnitine and Ginkgo biloba extract (EGb 761) in experimental bleomycin-induced lung fibrosis. Pharmacological Research 45, 461-467.
7. Entzian, P., Schlaak, M., Seitzer, U., Bufe, A., Acil, Y., Zabel, P., 1997. Anti-inflammatory properties of colchicines: implications for idiopathic pulmonary fibrosis. Lung 175, 41-51.
8. Filderman, A.E., Genovese, L.A., Lazo, J.S., 1988. Alternations in pulmonary protective enzymes following systemic bleomycin treatment in mice. Biochemical Pharmacology 37, 1111-1116.
9. Gao, Z.H., Huang, K.X., Xu, H.B., 1999. A study of free radical scavenging effects of flavonoids extracted from Scutellaria baicalensis Georgi in ESR. The Journal of Huazhong University of Science and Technology 27, 97-99.
10. Gong, L.K., Li, X.H., Wang, H., Zhang, L., Cai, Y., Qi, X.M., Liu, L.L., Liu, Y.Z., Wu, X.F., Chen, F.P., Huang, C.G., Ren, J., 2004. Feitai attenuates bleomycin-induced pulmonary fibrosis in rats. Biological and Pharmaceutical Bulletin 27, 634-640.
11. Gutteridge, J.M., Xiao Change, F., 1981. Protection of iron catalysed the radical damage to DNA and lipids by copper(II) bleomycin. Biochemical and Biophysical Research Communications 99, 1354-1360.
12. Hagiwara, S.I., Ishii, Y., Kitamura, S., 2000. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. American Journal of Respiratory and Critical Care Medicine 162, 225-231.
13. Hay, J., Shahzeidi, S., Laurent, G., 1991. Mechanisms of bleomycin-induced lung damage. Archives of Toxicology 65, 81-94.
14. Hesterberg, T.W., Gerriets, J.E., Reiser, K.M., Jackson, A.C., Cross, C.E., Last, J.A., 1981. Bleomycin-induced pulmonary fibrosis: correlation of biochemical, physiological, and histological changes. Toxicology and Applied Pharmacology 60, 360-367.
15. Hunninghake, G.W., Kalica, A.R., 1995. Approaches to the treatment of pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 151, 915-918.
16. International consensus statement, 2000. Idiopathic pulmonary fibrosis: diagnosis and treatment. American Journal of Respiratory and Critical Care Medicine 161, 646-664.
17. Izbicki, G., Segel, M.J., Christensen, T.G., Conner, M.W., Breuer, R., 2002. Time course of bleomycin-induced lung fibrosis. International Journal of Experimental Pathology 83, 111-119.
18. Jules-Elysee, K., White, D.A., 1990. Bleomycin-induced pulmonary toxicity. Clinics in Chest Medicine 11, 1-20.
19. Lasky, J.A., Ortiz, L.A., 2001. Antifibrotic therapy for the treatment of pulmonary fibrosis. The American Journal of the Medical Science 322, 213-221.
20. Lazenby, A.J., Crouch, E.C., McDonald, J.A., Kuhn, C.D., 1990. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, Type IV collagen and fibronectin. American Review of Respiratory Diseases 142, 206-214.
21. Lazo, J.S., Hoyt, D.G., Sebti, S.M., Pitt, B.R., 1990. Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacology and Therapeutics 47, 347-358.
22. MacNee, W., Rahman, I., 1995. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 50, 53-58.
23. Mapel, D.W., Samet, J.M., Coultas, D.B., 1996. Corticosteroid and treatment of idiopathic pulmonary fibrosis. Past, present and future. Chest 110, 1058-1067.
24. Martin, W.J., Kachel, D.L., 1987. Bleomycin-induced pulmonary endothelial cell injury: evidence for the role of iron-catalyzed toxic oxygen-derived species. Journal of Laboratory and Clinical Medicine 110, 153-158.
25. Mason, R.J., Schwarz, M.I., Hunninghake, G.W., Musson, R.A., 1999. NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. American Journal of Respiratory and Critical Care Medicine 160, 1771-1777.
26. Osanai, K., Takahashi, K., Sato, S., Iwabuchi, K., Ohtake, K., Sata, M., Yasui, S., 1991. Changes of lung surfactant and pressure-volume curve in bleomycin-induced pulmonary fibrosis. Journal of Applied Physiology 70, 1300-1308.
27. Oury, T.D., Thakker, K., Menache, M., Chang, L.Y., Crapo, J.D., Day, B.J., 2001. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. American Journal of Respiratory Cell and Molecular Biology 25, 164-169.
28. Shi, H.L., Zhao, B.L., Xin, W.J., 1995. Scavenging effects of baicalin on free radicals and its protection on erythrocyte membrane from free radical injury. Biochemistry and Molecular Biology International 35, 981-994.
29. Snider, G.L., 1983. Interstitial pulmonary fibrosis: which cell is the culprit? American Review of Respiratory Diseases 127, 535-539.
30. Swaisgood, C.M., French, E.L., Noga, C., Simon, R.H., Ploplis, V.A., 2000. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. American Journal of Pathology 157, 177-187.
31. Szapiel, S.V., Elson, N.A., Fulmer, J.D., Hunninghake, G.W., Crystal, R.G., 1979. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. American Review of Respiratory Diseases 120, 893-899.
32. Thrall, R.S., Swendsen, C.L., Shannon, T., Kennedy, C.A., Frederich, D.S., Grunze, M.F., Sulavik, S.B., 1987. Correlation of changes in pulmonary surfactant phospholipids with compliance in bleomycin-induced pulmonary fibrosis in the rat. American Review of Respiratory Diseases 136, 113-118.
33. Winkler, M.K., Fowlkes, J.L., 2002. Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? American Journal of Physiology, Lung Cellular and Molecular Physiology 283, 1-11.
34. Yamazaki, C., Hoshino, J., Sekiguchl, T., Hori, Y., Miyauchi, S., Mizuno, S., Horie, K., 1998. Production of superoxide and nitric oxide by alveolar macrophages in the bleomycin-induced interstitial pneumonia mice model. The Japanese Journal of Pharmacology 78, 69-73.
35. Zia, S., Hyde, D.M., Giri, S.N., 1992. Development of bleomycin hamster model of sub-chronic lung fibrosis. Pathology 24, 155-163.